Subramanian T, Chinnadurai G
St. Louis University School of Medicine, Institute for Molecular Virology, MO 63110.
Gene. 1992 Oct 21;120(2):287-9. doi: 10.1016/0378-1119(92)90107-z.
We have developed a vector (pSupexp), for high-level expression of genes, that is dependent on transactivation of the human immunodeficiency virus 1 (HIV-1) long terminal repeat (LTR) by the HIV-1 transactivator protein, Tat. The foreign gene, expressed under transcriptional control of the HIV-1 LTR, and the tat gene, expressed under transcriptional control of SV40 early promoter, are expressed from the same plasmid. The vector also has the neomycin resistance-encoding gene (neo), with G418 being used as a dominant selection marker for stable expression. We have cloned the bacterial cat gene into pSupexp and measured transient CAT production in human HeLa and A549 cells. Our results indicate that pSupexpCAT expresses about 25- to 68-fold higher levels of CAT activity as compared to other standard SV40- and Rous sarcoma virus-based vectors, and three- to fivefold more activity than the cytomegalovirus-based vector. Immunoprecipitation of the CAT protein also revealed a high level of production in human cells.
我们开发了一种用于基因高水平表达的载体(pSupexp),它依赖于人类免疫缺陷病毒1(HIV-1)反式激活蛋白Tat对HIV-1长末端重复序列(LTR)的反式激活。在HIV-1 LTR转录控制下表达的外源基因,以及在SV40早期启动子转录控制下表达的tat基因,都从同一质粒表达。该载体还具有新霉素抗性编码基因(neo),用G418作为稳定表达的显性选择标记。我们已将细菌氯霉素乙酰转移酶(cat)基因克隆到pSupexp中,并检测了其在人HeLa和A549细胞中的瞬时CAT产量。我们的结果表明,与其他基于标准SV40和劳斯肉瘤病毒的载体相比,pSupexpCAT表达的CAT活性水平高约25至68倍,比基于巨细胞病毒的载体活性高3至5倍。对CAT蛋白的免疫沉淀也显示其在人细胞中有高水平的产生。